Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Flipster FZE has obtained in-principle approval from Dubai's Virtual Assets Regulatory Authority (VARA), allowing the company to advance toward offering regulated virtual asset services with spot trading as its initial product. The milestone dovetails with Flipster's emphasis on compliance, including a partnership with Chainalysis, and follows the …
Sanofi has appointed Belén Garijo, 65, as its new chief executive after electing not to renew Paul Hudson's mandate. The move comes as the group contends with U.S. vaccine challenges and a lingering turnaround since 2019. Garijo brings prior Sanofi experience and recent leadership of Merck KGaA, where her record includes acquisitions, divestitures …
U.S. equity futures pointed higher on Thursday as investors looked past a stronger-than-forecast January nonfarm payrolls report and turned attention to upcoming corporate results and inflation data. The jobs report, which showed a 130,000 increase in payrolls and a decline in the unemployment rate to 4.3%, pushed back market expectations for the f…
Wells Fargo downgraded Inspire Medical Systems (INSP) from Overweight to Equal Weight and reduced its price target to $70 from $145, citing persistent uncertainty around physician reimbursement. The new target sits near the stock's recent trading level, after INSP shares fell sharply over the past year. Separate analyst action from Baird echoed rei…
Rothschild Redburn downgraded Arcellx Inc. (ACLX) from Buy to Neutral and reduced its price target to $82 from $113, pointing to rising competition in larger treatment markets across earlier multiple myeloma lines as the main factor. The firm kept a constructive view of Arcellx's anito-cel in late-line disease based on clinical data and a physician…
Cancom reported 0.9% year-on-year revenue growth in Q4 2025, marking a sequential acceleration after earlier declines in the year. EBITDA reached €38.6 million, an 8.0% margin versus 5.5% a year earlier, and cash flow strengthened in the quarter after a weaker first nine months of 2025. The company refrained from issuing 2026 guidance with prelimin…
AmBev delivered fourth-quarter results that broadly matched expectations on adjusted EBITDA but showed declines in volumes across most operating regions. Adjusted EBITDA came in at R$8.85 billion, 3% above analyst forecasts yet down 7.5% year-over-year. Total volumes fell 3.8% from a year earlier and missed analyst projections by 2.5%, with Brazil …
U.S. officials at APEC meetings in southern China are promoting American artificial intelligence products and maritime surveillance tools to bolster regional influence and counter Beijing. The Trump administration announced a $20 million fund to aid partner economies' adoption of U.S. AI technologies, while highlighting U.S. private-sector solution…
Samsung Electronics has started commercial shipments of its HBM4 high-bandwidth memory, becoming the first company to mass produce and ship this generation of memory. The company aims to reclaim market leadership after recent setbacks, is expanding capacity and expects substantial revenue growth from its HBM business by 2026. Competitors are also p…
Laidlaw Securities reaffirmed a Buy rating on Viking Therapeutics (VKTX) and set a $110 price target after the company reported fourth-quarter 2025 financial results and corporate updates. The firm highlighted clearer development paths for VK2735 in both subcutaneous and oral forms and noted Viking's strong cash position. The company also reported …
Tietoevry reported fourth-quarter revenue a touch below consensus while outperforming on adjusted EBITA and margin after accelerated cost optimization. The company raised multi-year savings targets, outlined guidance for 2026 with continued growth headwinds, proposed a smaller dividend and launched a share buyback tied to a divestment.
Indonesian equities ended the session lower, with the IDX Composite Index closing down 0.65% in Jakarta. Losses were led by the Infrastructure, Financials and Agriculture sectors. A handful of small-cap winners posted double-digit gains, while several stocks dropped sharply, including one that hit an all-time low. Commodity and FX moves were modest…
JPMorgan downgraded Valvoline to Underweight from Neutral and set a new price target of $35, even as it raised that target from $30. The bank expects the integration of 162 Breeze locations to compress margins in fiscal 2026 and to raise pre-tax interest costs, risks that it says will outweigh benefits from lower base oil prices. Valvoline recently…
JPMorgan on Thursday downgraded Kraft Heinz from Neutral to Underweight and reduced its price target to $22 from $24. The move follows a fourth-quarter 2025 earnings beat that was supported by favorable SG&A and tax items, but JPMorgan highlighted below-consensus 2026 organic sales and EPS guidance, ongoing North America volume declines, and potent…
JPMorgan upgraded MercadoLibre from Neutral to Overweight and increased its price target to $2,800 from $2,650. The bank cited a less aggressive competitive environment following Shopee’s take rate increase, reduced downside risk to 2026-27 consensus estimates, and an expectation that MercadoLibre can sustain over 30% growth in Brazil in Q4 2025. T…
Rothschild Redburn reduced its rating on Legend Biotech (LEGN) from Buy to Neutral and cut the firm's price target from $83.00 to $24.00 after identifying competitive risks to Carvykti at ASH 2025. The firm also trimmed its peak sales forecast for the drug to about $6 billion from roughly $10 billion. Other analysts have reacted with a range of adj…
Baird downgraded Inspire Medical Systems (NYSE:INSP) from Outperform to Neutral and reduced its price target to $74 from $130, citing reimbursement headwinds and a trimmed fiscal 2026 outlook. The stock, trading around $68.21, has lost more than 63% over the past year and sits just above its 52-week low. Despite a sizable Q4 2025 earnings beat, the…
European shares rose to a fresh record high on Thursday as better-than-expected corporate updates and a major takeover in asset management supported sentiment. The STOXX 600 climbed, led by a strong performance in French stocks after Legrand and Hermès posted encouraging results, while Schroders surged following a proposed acquisition by Nuveen. In…
Barclays moved Pegasystems (NASDAQ: PEGA) from Equalweight to Overweight and trimmed its price target to $48.00 from $67.00, citing the company’s positioning in complex business process software and progress integrating AI into its Blueprint product. The upgrade coincides with Pegasystems reporting stronger-than-expected fourth-quarter 2025 results…
B. Riley has initiated coverage of Fennec Pharmaceuticals (NASDAQ: FENC) with a Buy rating and set a $16.00 price target, arguing that the market underprices PEDMARK's commercial prospects despite strong margin and revenue growth expectations. The firm flagged several near-term catalysts in 1Q/1H26 and noted the company has repaid all outstanding c…
European equities advanced on Thursday as investors parsed an extensive round of corporate earnings and digested U.K. growth figures. Major indexes in Germany, France and the U.K. gained, led by a mix of stronger-than-expected corporate updates and uneven results from a range of sectors. Mercedes Benz reported a sharp drop in profit and warned of m…
NN Group NV reported robust full-year 2025 results, with operating capital generation and solvency ratio ahead of market forecasts. The insurer proposed a higher-than-expected dividend, announced a €350 million buyback and flagged portfolio adjustments in response to rising disability claims related to long COVID.
Verisure PLC reported a standout fourth quarter driven by a record number of new installations, delivering annual recurring revenue growth that exceeded the company’s guidance. The security services provider widened margins in the quarter and closed 2025 with higher customer counts, modestly stronger operating profit than forecast, and guidance for…
Amazon is a $2.19 trillion company with durable franchise businesses, but the combination of negative free cash flow, a rich earnings multiple and a $200 billion AI capex plan makes current risk/reward tilted toward a corrective move. This is a mid-term (45 trading days) short idea sized for active traders who can handle headline risk.
Nextensa said it will propose a €1.00 dividend at its annual general meeting after reporting a return to profitability in fiscal 2025. The company logged a sharp fall in rental income driven by asset disposals but offset this with portfolio sales, lower net debt and higher earnings, while preparing to advance key development projects in 2026.
